Angiotensin II receptor type 1 gene expression in human glomerulonephritis and diabetes mellitus

Journal of the American Society of Nephrology

Volumn 10, Issue 3, 1999, Pages 545-551

  Wagner, Jürgen ^a,b   Gehlen, Frank ^a   Ciechanowicz, Andrzej ^a   Ritz, Eberhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; MESSENGER RNA; RENIN;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; GENE EXPRESSION; GLOMERULONEPHRITIS; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033019010     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77: 1993-1999, 1986
2. Maki DD, Ma JZ, Louis TA, Kasiske BL: Long-term effects of antihypertensive agents on proteinuria and renal function. Arch Intern Med 155: 1073-1080, 1995
3. Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, Ponticelli C, Ritz E, Zuchelli P, for the Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334: 939-945, 1996
4. Lafayette RA, Mayer G, Park SK, Meyer TW: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 91: 766-771, 1992
5. Raij L, Shultz PJ, Tolins PJ: Possible mechanism for the reno-protective effect of angiotensin converting enzyme inhibitors. J Hypertens 7: S33-S37, 1989
6. Nakamura N, Soubrier F, Menard J, Panthier JJ, Rougeon F, Corvol P: Nonproportional changes in plasma renin concentration, renal renin content, and rat renin messenger RNA. Hypertension (Dallas) 7: 855-859, 1989
7. Wagner J, Volk S, Haufe CC, Ciechanowicz A, Paul M, Ritz E: Renin gene expression in human kidney biopsies from patients with glomerulonephritis or graft rejection. J Am Soc Nephrol 5: 1469-1475, 1995
8. Burns KD, Homma T, Harris RC: The intrarenal renin-angiotensin system. Semin Nephrol 13: 13-30, 1993
9. Cassis LA: Downregulation of the renin-angiotensin system in streptozotocin-diabetic rats. Am J Physiol 262: E105-E109, 1992
10. Douglas JG: Corticosteroids decrease glomerular angiotensin receptor. Am J Physiol 252: F453-F457, 1987
11. Peten EP, Striker LJ, Carome MA, Elliot SJ, Yang CW, Striker GE: The contribution of increased collagen synthesis to human glomerulosclerosis: A quantitative analysis of α2IV collagen mRNA expression by competitive polymerase chain reaction. J Exp Med 176: 1571-1576, 1992
12. Carome MA, Striker LJ, Peten EP, Moore J, Yang CW, Stetler-Stevenson WG, Striker GE: Human glomeruli express TIMP-1 mRNA and TIMP-2 protein and mRNA. Am J Physiol 264: F923-F929, 1994
13. Wang AM, Doyle MV, Mark DF: Quantification of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 86: 9717-9721, 1989
14. Paul M, Wagner J, Dzau VJ: Gene expression of the renin angiotensin system in human tissues: Quantitative analysis by the polymerase chain reaction. J Clin Invest 91: 2058-2064, 1993
15. Krukoff TL, Gehlen F, Ganten D, Wagner J: Gene expression of brain nitric oxide synthase (bNOS) and soluble guanylyl cyclase (sGC) in hypothalamus and medulla of hypertensive rats. Hypertension (Dallas) 26: 171-176, 1995
16. Iwano M, Akai Y, Fuji Y, Dohi Y, Matsumura N, Dohi K: Intraglomerular expression of transforming growth factor-β1 mRNA in patients with glomerulonephritis: Quantitative analysis by competitive polymerase chain reaction. Clin Exp Immunol 97: 309-314, 1994
17. Sharma VK, Bologa RM, Xu GP, Li B, Mouradian J, Wang J, Serur D, Rao V, Suthanthiran M: Intragraft TGF-β1 mRNA: A correlate of interstitial fibrosis and chronic allograft nephropathy. Kidney Int 49: 1297-1303, 1996
18. Pannetier C, Delassus S, Darche S, Saucier C, Kourilsky P: Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation. Nucleic Acids Res 21: 577-583, 1993
19. Peten EP, Striker LJ, Garcia-Perez A, Striker GE: Studies by competitive PCR of glomerulosclerosis in growth hormone transgenic mice. Kidney Int 43[Suppl 39]: S55-S58, 1993
20. Siebert PD: Quantitative RT-PCR: Methods and Applications, Book 3, Palo Alto, CA, Clontech Laboratories, 1993
21. Siebert PD, Larrick JW: Competitive PCR. Nature (Lond) 259: 557-558, 1992
22. Akai Y, Iwano M, Kitamura Y, Shiiki H, Dohi Y, Dohi K, Moryiama T, Yonemasu K: Intraglomerular expressions of IL-1α and platelet-derived growth factor mRNA in experimental immune-complex mediated glomerulonephritis. Clin Exp Immunol 95: 29-34, 1994
23. Della-Bruna R, Kurtz A, Corvol P, Pinet F: Renin mRNA quantification using polymerase chain reaction in cultured juxtaglomerular cells: Short term effects of cAMP on renin mRNA and secretion. Circ Res 73: 639-648, 1993
24. Yokoi H, Natsuyama S, Iwai M, Noda Y, Mori T, Mori KJ, Fujita K, Nakayama H, Fujita J: Non-radioisotopic quantitative RT-PCR to detect changes in mRNA levels during early mouse embryo development. Biochem Biophys Res Commun 195: 769-775, 1993
25. Iwai N, Inagami T: Regulation of the expression of the rat angiotensin II receptor mRNA. Biochem Biophys Res Commun 182: 1094-1099, 1992
26. Amiri F, Garcia R: Renal angiotensin II receptor regulation in two-kidney, one-clip hypertensive rats: Effect of ACE inhibition. Hypertension (Dallas) 30: 337-344, 1997
27. Steffen MW, Bilous IW, Sutherland DER, Mauer SM: Cell and matrix components of the glomerular mesangium in type 1 diabetes. Diabetes 41: 679-685, 1992
28. Anderson S, Jung FF, Ingelfinger JR: Renal renin-angiotensin system in diabetes: Functional, immunohistochemical, and molecular biological correlations. Am J Physiol 265: F477-F486, 1993
29. Makita N, Iwai N, Inagami T, Badr K: Two distinct pathways in the down-regulation of type-1 angiotensin II receptor gene in rat glomerular mesangial cells. Biochem Biophys Res Commun 185: 142-146, 1992
30. Chansel D, Bizet T, Vandermeersch S, Pham P, Levy B, Ardaillou R: Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesangial cells. Am J Physiol 266: F384-F393, 1994
31. Cheng HF, Becker BN, Burns KD, Harris RC: Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest 95: 2012-2019, 1995
32. Beretta-Piccoli C, Weidmann P, de Chatel R, Reubi F: Hypertension associated with early stage kidney disease: Complementary role of circulating renin, the body sodium/volume state and duration of hypertension. Am J Med 61: 739-747, 1976
33. Schalekamp MA, Beevers DG, Briggs JD: Hypertension in chronic renal failure: An abnormal relation between sodium and the renin-angiotensin system. Am J Med 55: 379-390, 1973